MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Development of the CONSORTIUM FOR GLOBAL DIVERSITY IN PARKINSON’S DISEASE (CDG-PD) Patient Database

    J. Bajwa, M. Salari, S. Khan, H. Amer, A. Al-Qassabi, A. Habib, J. Habib, M. Abu Al-Melh, M. Abu Snineh, Q. Un Nisa, S. Zaidi, A. Dahshan, W. Regragui, J. Ahmed, H. Shehata, I. Hashmat, N. Ullah Bullo, S. Om Mittal, T. Mohammad, W. Kamel, T. Houyam, S. Eljaffery, R. Rajan, M. Farghal, F. Abdulla, Z. Al-Daajani, P. Schmidt, H. Khalil (Riyadh, Saudi Arabia)

    Objective: To describe the development and organization of the Consortium for Global Diversity in Parkinson’s Disease (CDG-PD), created in 2020 with a broad aim to…
  • MDS Virtual Congress 2021

    The PRIME Qual study protocol: A qualitative exploration of the experiences of patients, caregivers/families and hospital/intervention staff of the PRIME Randomised Controlled Trial

    H. Brant, E. Henderson, D. Gervaise-Brazier, F. Lithander, E. Tenison, S. Redwood (Bristol, United Kingdom)

    Objective: This qualitative study seeks to  understand how a new model of care influences a person with Parkinson’s ability to stay well physically, maintain their…
  • MDS Virtual Congress 2021

    Association between Alzheimer’s disease co-pathology and neuropsychiatric symptoms in Lewy body dementia

    J. Dipane, D. Coughlin, E. Bayram (La Jolla, USA)

    Objective: To identify the associations between Alzheimer Disease (AD) co-pathology and neuropsychiatric symptoms in Lewy body dementia (LBD). Background: Dementia with Lewy Bodies (DLB) and…
  • MDS Virtual Congress 2021

    Long-term cognitive and motor decline across the spectrum of Lewy body disease.

    MC. Gonzalez, J. Maple-Grødem, D. Tovar‐rios, CH. Williams-Gray, M. Camacho, L. Forsgren, D. Bäckström, R. Lawson, AD. Macleod, CE. Counsell, C. Paquet, C. Falup-Pecurariu, F. Blanc, A. Padovani, C. de Lena, F. D'Antonio, G. Alves, D. Aarsland (Stavanger, Norway)

    Objective: This study aims to compare the progression of motor and cognitive decline in dementia with Lewy bodies (DLB) compared with Parkinson’s disease (PD) using…
  • MDS Virtual Congress 2021

    Challenges in Implementing Relevant Exercise Interventions in Mouse Models of Parkinson’s Disease

    D. Grogan, H. Skelton, J. Rubiano, C. Gutekunst, R. Gross (Augusta, USA)

    Objective: To determine the suitability of a motorized wheel as a forced exercise modality that does not rely on aversive stimuli for use in Parkinson’s…
  • MDS Virtual Congress 2021

    Spatiotemporal dynamics in mild cognitive impairment with Lewy bodies

    M. Lamoš, I. Morávková, D. Ondráček, M. Bočková, I. Rektorová (Brno, Czech Republic)

    Objective: To explore whether EEG microstate evaluation may help in identifying mild cognitive impairment with Lewy bodies (MCI-LB) and to assess whether the changes correlate…
  • MDS Virtual Congress 2021

    Cardiovascular risk factors and phenoconversion to neurodegenerative synucleinopathies in idiopathic REM sleep behavior disorder

    N. Lewandowski, S. Zolfaghari, A. Pelletier, S A. Naeimi, J-F. Gagnon, M. Brillon-Corbeil, J. Montplaisir, R. Postuma (Montreal, Canada)

    Objective: To evaluate the predictive role of cardiovascular diseases and metabolic risk factors in the phenoconversion of idiopathic REM sleep behavior disorder (iRBD) patients. Background:…
  • MDS Virtual Congress 2021

    Effects of white matter hyperintensities, neuropsychiatric symptoms, and cognition on activities of daily living: Differences between Dementia with Lewy Bodies and Alzheimer’s disease

    S. Mirza, U. Saeed, J. Ramirez, N. Herrmann, S. Black, M. Masellis (Toronto, Canada)

    Objective: To investigate if White matter hyperintensities (WMHs), neuropsychiatric symptoms and cognitive performance associate with, and/or predict activities of daily living (ADLs) differently in Alzheimer’s…
  • MDS Virtual Congress 2021

    Risk factors for the onset of dyskinesia in patients with Parkinson’s disease exhibiting wearing-off phenomena: A 1-year observational study in Japan (J-FIRST)

    T. Mishima, SW. Chiu, H. Saiki, T. Yamaguchi, Y. Shimo, T. Maeda, H. Watanabe, K. Kashihara, M. Nomoto, N. Hattori, Y. Tsuboi (Fukuoka, Japan)

    Objective: To investigate the risk factors for the onset of dyskinesia in patients with Parkinson's disease (PD) exhibiting wearing-off phenomena. Background: Dyskinesia occurs during long-term…
  • MDS Virtual Congress 2021

    Rapidly progressive dementia after MRI-guided Focused Ultrasound (MR-FUS)

    JM. Perez Imbernon, S. Lopez Calvo, F. Castillo Alvarez, MT. Marti Sanchez, MM. Zambrano Vera, N. Reurich Gomez, ME. Marzo Sola (Logroño, Spain)

    Objective: To present a Parkinson´s Disease (PD) patient who presented a rapidly progressive dementia after MR-FUS therapy. Background: MR-FUS thalamotomy is used for unilateral essential…
  • « Previous Page
  • 1
  • …
  • 757
  • 758
  • 759
  • 760
  • 761
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley